Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Special clinical nutrition formula for epileptics and preparation method thereof

A nutritional formula and special-purpose technology, which is applied in the field of special clinical nutritional formula for epilepsy patients and its preparation, can solve the problems of many side effects, slow onset of effect, poor effect, etc., and achieve the effect of treating epilepsy symptoms and relieving side effects

Inactive Publication Date: 2018-05-29
上海奥医生物医药科技有限公司
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, a ketogenic diet may be less effective for partial than generalized epilepsy
[0009] At present, the clinical treatment of epilepsy is still mainly based on oral antiepileptic drugs. Oral antiepileptic drugs have many side effects. The ketogenic diet has limitations in the clinical treatment of epilepsy. It is only effective for some epilepsy, and the ketogenic diet also ignores Effects of Other Nutrients on Seizures
Western medicine mainly relies on antiepileptic drugs to treat epilepsy. Although the effect is rapid, there are many side effects, and the patient's compliance and tolerance are poor.
In recent years, clinical studies have found that traditional Chinese medicine has definite effects in treating this disease, with few side effects, but the onset of effect is slow

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Special clinical nutrition formula for epileptics and preparation method thereof
  • Special clinical nutrition formula for epileptics and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] The special clinical nutritional formula for epileptic patients according to the present invention includes 6.7g of whey protein powder, 3.33g of soybean protein isolate, 11.4g of whole milk powder, 0.17g of bovine colostrum powder, 0.2g of marine fish oligopeptide, taurine 0.13g; olive oil 13g, soybean oil 21g, coconut oil 13g, perilla oil 3g, medium chain triglycerides 1.7g; maltodextrin 4.58g, rock sugar 2.33g; water-soluble dietary fiber 5.33g, soybean fiber 3.33g; Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macro elements; iron 0.015g, zinc 0.013g in trace elements; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, Vitamin E 0.009g; Vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; carrot powder 0.2g, red bean powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, poria cocos 0.01g, jujube s...

Embodiment 2

[0075] The special clinical nutritional formula for epileptic patients according to the present invention includes 6.7g of whey protein powder, 3.33g of soybean protein isolate, 11.4g of whole milk powder, 0.17g of bovine colostrum powder, 0.2g of marine fish oligopeptide, taurine 0.13g; olive oil 13g, soybean oil 21g, coconut oil 13g, perilla oil 3g, medium chain triglycerides 1.7g; maltodextrin 4.58g, rock sugar 2.33g; water-soluble dietary fiber 5.33g, soybean fiber 3.33g; Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macro elements; iron 0.015g, zinc 0.013g in trace elements; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, Vitamin E 0.009g; Vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; carrot powder 0.2g, red bean powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, Poria cocos 0.2g, jujube se...

Embodiment 3

[0077] The special clinical nutritional formula for epileptic patients according to the present invention includes 6.7g of whey protein powder, 3.33g of soybean protein isolate, 11.4g of whole milk powder, 0.17g of bovine colostrum powder, 0.2g of marine fish oligopeptide, taurine 0.13g; olive oil 10g, soybean oil 11g, coconut oil 10g, perilla oil 1g, medium chain triglycerides 1.7g; maltodextrin 22.58g, rock sugar 2.33g; water-soluble dietary fiber 5.33g, soybean fiber 3.33g; Calcium 0.53g, phosphorus 0.24g, potassium 0.1g, sodium 0.07g, magnesium 0.174g in macro elements; iron 0.015g, zinc 0.013g in trace elements; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, Vitamin E 0.009g; Vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; carrot powder 0.2g, red bean powder 0.2g, broccoli powder 0.2g, white fungus powder 0.2g, poria cocos 0.01g, jujube ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a special clinical nutrition formula for epileptics. The nutrition formula comprises the following components in parts by weight: 10-22 parts of protein, 32-55 parts of fat, 6-25 parts of carbohydrate, 7-9 parts of dietary fiber, 0.6-1.2 parts of major elements, 0.01-0.04 part of trace elements, 0.005-0.03 part of fat-soluble vitamin, 0.008-0.2 part of water-soluble vitamin,0.05-1 part of dietary essence, 0.06-2 parts of medicinal and food homologous ingredients, and 0.005-2 parts of new source food. The invention further provides a preparation method of the clinical nutrition formula. The clinical nutrition formula can cure epilepsy and can relieve the side effects of ketogenic diet.

Description

technical field [0001] The invention relates to the field of formula food for special medical purposes, in particular to a special clinical nutritional formula for epilepsy patients and a preparation method thereof. Background technique [0002] Epilepsy is a disorder of the brain characterized by a persistent susceptibility to recurrent epileptic seizures in brain tissue, and the resulting neurobiochemical, cognitive, psychological, and social consequences. At present, there are about 50×106 epilepsy patients in the world, 80% of which are in developing countries. There are about 9×106 patients in my country, and there are still more than 450×103 new cases every year. Currently, there are about 6.50×106 active cases, of which Rural areas account for about 2 / 3, and the treatment gap reaches 70%. At present, the treatment of epilepsy is still based on long-term oral antiepileptic drugs (AEDs), especially for some types of intractable epilepsy, which often require a combinatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/00A23L33/10A23L33/12A23L33/125A23L33/15A23L33/155A23L33/16A23L33/17A23L33/175A23L33/18A23L33/185A23L33/19A23L33/21A23L33/22A23L33/26
CPCA23L33/10A23L33/12A23L33/125A23L33/15A23L33/155A23L33/16A23L33/17A23L33/175A23L33/18A23L33/185A23L33/19A23L33/21A23L33/22A23L33/26A23L33/40A23V2002/00A23V2250/54252A23V2250/5488A23V2250/55A23V2250/0644A23V2250/18A23V2250/1944A23V2250/5114A23V2250/628A23V2250/5116A23V2250/1578A23V2250/1618A23V2250/16A23V2250/161A23V2250/1614A23V2250/1592A23V2250/1642A23V2250/702A23V2250/7106A23V2250/712A23V2250/7042A23V2250/7044A23V2250/7052A23V2250/706A23V2250/708A23V2250/705A23V2250/7056A23V2250/7046A23V2250/038A23V2200/322A23V2250/211
Inventor 尤俊季敬东
Owner 上海奥医生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com